ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 5,800.00
-120.00 (-2.03%)
Sep 1, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 65.29 billion as of September 1, 2026. Its market cap has decreased by -42.47% in one year.
Market Cap
65.29B
Enterprise Value
47.03B
Revenue
4.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,800.00
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 65.29B, a decrease of -59.40%. That is a compound annual growth rate of -35.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 65.29B | -67.11% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 138.14B |
| Genexine | 124.39B |
| MedPacto | 93.91B |
| Vaxcell-Bio Therapeutics | 93.03B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 77.28B |
| Amicogen | 68.34B |
| ORIENT BIO | 52.11B |